Follow
Michael Lanuti
Michael Lanuti
Associate Professor of Surgery, Harvard Medical School
Verified email at partners.org
Title
Cited by
Cited by
Year
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
LV Sequist, BA Waltman, D Dias-Santagata, S Digumarthy, AB Turke, ...
Science translational medicine 3 (75), 75ra26-75ra26, 2011
37342011
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
DS Ettinger, DE Wood, DL Aisner, W Akerley, J Bauman, LR Chirieac, ...
Journal of the National Comprehensive Cancer Network 15 (4), 504-535, 2017
12252017
Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022
9452022
NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 19 (3), 254-266, 2021
8872021
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes
H Zhuang, M Pourdehnad, ES Lambright, AJ Yamamoto, M Lanuti, P Li, ...
Journal of Nuclear Medicine 42 (9), 1412-1417, 2001
7952001
NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, C Aggarwal, DL Aisner, W Akerley, JR Bauman, ...
Journal of the National Comprehensive Cancer Network 17 (12), 1464-1472, 2019
6942019
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
CA Shu, JF Gainor, MM Awad, C Chiuzan, CM Grigg, A Pabani, ...
The Lancet Oncology 21 (6), 786-795, 2020
5262020
NCCN guidelines insights: non–small cell lung cancer, version 5.2018
DS Ettinger, DL Aisner, DE Wood, W Akerley, J Bauman, JY Chang, ...
Journal of the National Comprehensive Cancer Network 16 (7), 807-821, 2018
5222018
NCCN guidelines insights: non–small cell lung cancer, version 4.2016
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 14 (3), 255-264, 2016
4782016
Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice
LV Sequist, RS Heist, AT Shaw, P Fidias, R Rosovsky, JS Temel, ...
Annals of Oncology 22 (12), 2616-2624, 2011
4752011
Non–small cell lung cancer, version 6.2015
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 13 (5), 515-524, 2015
4052015
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
BC Fuchs, T Fujii, JD Dorfman, JM Goodwin, AX Zhu, M Lanuti, ...
Cancer research 68 (7), 2391-2399, 2008
4022008
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
BC Fuchs, Y Hoshida, T Fujii, L Wei, S Yamada, GY Lauwers, CM McGinn, ...
Hepatology 59 (4), 1577-1590, 2014
3572014
Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis
KK Tanabe, A Lemoine, DM Finkelstein, H Kawasaki, T Fujii, RT Chung, ...
Jama 299 (1), 53-60, 2008
2592008
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor
T Fujii, BC Fuchs, S Yamada, GY Lauwers, Y Kulu, JM Goodwin, M Lanuti, ...
BMC gastroenterology 10, 1-11, 2010
2382010
NCCN guidelines® Insights: non–small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ...
Journal of the National Comprehensive Cancer Network 21 (4), 340-350, 2023
2372023
Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma
KL Molnar-Kimber, DH Sterman, M Chang, EH Kang, M ElBash, M Lanuti, ...
Human gene therapy 9 (14), 2121-2133, 1998
2331998
Non–small cell lung cancer, version 1.2015
DS Ettinger, DE Wood, W Akerley, LA Bazhenova, H Borghaei, ...
Journal of the National Comprehensive Cancer Network 12 (12), 1738-1761, 2014
2262014
SELECT: a phase II trial of adjuvant erlotinib in patients with resected epidermal growth factor receptor–mutant non–small-cell lung cancer
NA Pennell, JW Neal, JE Chaft, CG Azzoli, PA Jänne, R Govindan, ...
Journal of Clinical Oncology 37 (2), 97-104, 2019
2212019
Deep learning classification of lung cancer histology using CT images
TL Chaunzwa, A Hosny, Y Xu, A Shafer, N Diao, M Lanuti, DC Christiani, ...
Scientific reports 11 (1), 1-12, 2021
1952021
The system can't perform the operation now. Try again later.
Articles 1–20